Senior HEMA Manager - Structural Heart Valves (SHV)

Additional Location(s): US-MN-Maple Grove; US-MN-Arden Hills

Diversity - Innovation - Caring - Global Collaboration - Winning Spirit - High Performance

At Boston Scientific, we’ll give you the opportunity to harness all that’s within you by working in teams of diverse and high-performing employees, tackling some of the most important health industry challenges. With access to the latest tools, information and training, we’ll help you in advancing your skills and career. Here, you’ll be supported in progressing – whatever your ambitions.                

About the role:

The Sr. HEMA Manager will lead the development and implementation of health policy and reimbursement initiatives in support of Boston Scientific’s Interventional Cardiology Business Unit. This role involves cross-functional and global collaboration to ensure appropriate reimbursement for existing and emerging technologies. The individual will be responsible for providing strategic input to product development teams.

Your responsibilities will include:

• Lead the development and implementation of market access and reimbursement strategies for the assigned product portfolio, in collaboration with cross-functional colleagues.
• Lead execution of market access and reimbursement strategies in the US and support implementation in global markets.
• Identify and influence health policy developments that impact reimbursement of BSC products and educate key stakeholders. 
• Lead reimbursement initiatives required to achieve health economics and market access strategic objectives (e.g. coding applications, clinical trial reimbursement, data analytics).
• Serve as primary HEMA representative for cross-functional teams. Guide the development and communication of economic value messages to support product adoption.
• Identify evidence development needs and ensure data-driven support for HEMA initiatives, through collaboration with HEMA Analysts and HEOR team (e.g. market assessments, forecasting, pricing strategies and RWE analyses)
• Oversee development of comprehensive reimbursement, economic and health policy resources for Field HEMA team to ensure ongoing support for sales and key external stakeholders (e.g., hospitals, clinicians, investigator sites).
• Engage with physician and administrative customers at on-site Boston Scientific events (e.g. Advisory Board) and in the field, including at Scientific Symposia.

Required Qualifications

• Bachelor’s degree or equivalent
• 7+ years of experience in the medical industry, including experience supporting reimbursement strategies for a medical device manufacturer
• Strong understanding of US health care policy and payment systems, including hospital and physician reimbursement
• Experience with health policy development and Federal rule making processes (e.g. CMS)
• Experience working with internal and external stakeholders at the C-suite level
• Computer literacy (Microsoft Office Suite)
• Domestic travel estimated at 25%, including overnight travel

Preferred qualifications

• Advanced degree such as an MS, MPH, MBA, MPH, MHA in health policy, health economics, healthcare administration, health services research, or similar discipline 
• Interventional Cardiology industry experience
• Strong understanding of CMS payment systems, including hospital inpatient, hospital outpatient, ASC and physician fee schedule
• Expertise in global market access requirements
• Experience with new technology reimbursement pathways, particularly for medical devices

Requisition ID: 587530

As a leader in medical science for more than 40 years, we are committed to solving the challenges that matter most – united by a deep caring for human life. Our mission to advance science for life is about transforming lives through innovative medical solutions that improve patient lives, create value for our customers, and support our employees and the communities in which we operate. Now more than ever, we have a responsibility to apply those values to everything we do – as a global business and as a global corporate citizen.

So, choosing a career with Boston Scientific (NYSE: BSX) isn’t just business, it’s personal. And if you’re a natural problem-solver with the imagination, determination, and spirit to make a meaningful difference to people worldwide, we encourage you to apply and look forward to connecting with you!

At Boston Scientific, we recognize that nurturing a diverse and inclusive workplace helps us be more innovative and it is important in our work of advancing science for life and improving patient health. That is why we stand for inclusion, equality, and opportunity for all. By embracing the richness of our unique backgrounds and perspectives, we create a better, more rewarding place for our employees to work and reflect the patients, customers, and communities we serve. Boston Scientific is proud to be an equal opportunity and affirmative action employer.

Boston Scientific maintains a prohibited substance free workplace. Pursuant to Va. Code § 2.2-4312 (2000), Boston Scientific is providing notification that the unlawful manufacture, sale, distribution, dispensation, possession, or use of a controlled substance or marijuana is prohibited in the workplace and that violations will result in disciplinary action up to and including termination.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status.  Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment.  Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements.   As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.